Berlin, Germany

Renate Grupe

This inventor holds 1 USPTO granted patent. Top assignee: Veb Arzneimittelwerk Dresden. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renate Grupe. Retrieved from https://idiyas.com/inventor/renate-grupe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Renate Grupe: Innovator in Pharmaceutical Chemistry

Introduction

Renate Grupe is a distinguished inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on hydroxamic acids. Her research has led to the development of compounds with valuable pharmacological properties.

Latest Patents

Renate Grupe holds a patent for "Hydroxamic acid and pharmaceutical preparations containing the same." This patent describes new ω-(2'-naphthoxy)-alkylhydroxamic acids and a process for their production. The new compounds exhibit antiasthmatic properties and other pharmacologically valuable characteristics. They are synthesized by reacting the corresponding carboxylic acid ester or amide with hydroxylamine or its salt under specific conditions.

Career Highlights

Renate Grupe has worked at Veb Arzneimittelwerk Dresden, where she has been instrumental in advancing pharmaceutical research. Her innovative approach has led to the creation of new therapeutic agents that can improve patient outcomes.

Collaborations

Renate has collaborated with notable colleagues, including Thomas Strumpf and Tankred Schewe, to further her research and development efforts in the pharmaceutical field.

Conclusion

Renate Grupe's contributions to pharmaceutical chemistry, particularly through her patent on hydroxamic acids, highlight her role as an influential inventor. Her work continues to impact the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…